======= FBXO32 ======= == Gene Information == * **Official Symbol**: FBXO32 * **Official Name**: F-box protein 32 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=114907|114907]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q969P5|Q969P5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FBXO32&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FBXO32|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606604|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins during skeletal muscle atrophy. Recognizes TERF1. {ECO:0000269|PubMed:15531760}. No Pfam Domain information is available for this gene. |response to denervation involved in regulation of muscle adaptation| |response to muscle inactivity involved in regulation of muscle adaptation| |response to muscle inactivity| |response to inactivity| |response to stimulus involved in regulation of muscle adaptation| |cellular response to dexamethasone stimulus| |response to dexamethasone| |cellular response to glucocorticoid stimulus| |cellular response to corticosteroid stimulus| |SCF ubiquitin ligase complex| |regulation of muscle adaptation| |cellular response to ketone| |response to antineoplastic agent| |Z disc| |response to glucocorticoid| |response to corticosteroid| |cellular response to xenobiotic stimulus| |cellular response to steroid hormone stimulus| |response to ketone| |regulation of muscle system process| |protein polyubiquitination| |response to xenobiotic stimulus| |response to steroid hormone| |post-translational protein modification| |cellular response to drug| |cellular response to lipid| |cellular response to organic cyclic compound| |regulation of system process| |cellular response to hormone stimulus| |protein ubiquitination| |protein modification by small protein conjugation| |response to lipid| |response to hormone| |response to organic cyclic compound| |protein modification by small protein conjugation or removal| |response to drug| |cellular response to oxygen-containing compound| |cellular response to endogenous stimulus| |response to endogenous stimulus| |response to oxygen-containing compound| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.75| |[[:results:exp11|CCCP 1μM R00 exp11]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12912 * **Expression level (log2 read counts)**: 0.58 {{:chemogenomics:nalm6 dist.png?nolink |}}